AQS.V - Aequus Pharmaceuticals Inc.
TSXV - TSXV Delayed Price. Currency in CAD
0.1400
+0.0100 (+7.69%)
At close: 3:50PM EST
Stock chart is not supported by your current browser
| Previous Close | 0.1300 |
| Open | 0.1350 |
| Bid | 0.1350 x 0 |
| Ask | 0.1400 x 0 |
| Day's Range | 0.1350 - 0.1400 |
| 52 Week Range | 0.0900 - 0.2450 |
| Volume | 131,500 |
| Avg. Volume | 92,924 |
| Market Cap | 11.261M |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Imagine Owning Aequus Pharmaceuticals (CVE:AQS) While The Price Tanked 56%
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...
- Simply Wall St.
Should You Worry About Aequus Pharmaceuticals Inc.'s (CVE:AQS) CEO Pay?
Doug Janzen has been the CEO of Aequus Pharmaceuticals Inc. (CVE:AQS) since 2014. First, this article will compare CEO...
- Simply Wall St.
Do Directors Own Aequus Pharmaceuticals Inc. (CVE:AQS) Shares?
If you want to know who really controls Aequus Pharmaceuticals Inc. (CVE:AQS), then you'll have to look at the makeup...
- Simply Wall St.
Some Aequus Pharmaceuticals (CVE:AQS) Shareholders Have Copped A Big 63% Share Price Drop
If you love investing in stocks you're bound to buy some losers. But the last three years have been particularly tough on longer term Aequus Pharmaceuticals Inc. (CVE:AQS) shareholders. So they might be feeling emotional abou...
